If you're seeking detailed information about the clinical studies behind Tadalista Professional, it's important to note that this medication is a generic version of Tadalafil, marketed under the brand name Cialis. The clinical research supporting Tadalafil's efficacy and safety primarily pertains to Cialis.
For comprehensive insights into the clinical studies of Tadalafil, you can refer to several reputable sources:
European Urology Journal: This journal published an integrated analysis of data from six randomized, double-blind, placebo-controlled clinical studies involving 1,913 patients. The study evaluated the efficacy of once-daily Tadalafil 2.5 mg and 5 mg in improving erectile function. The results indicated significant improvements in erectile function across various severities of erectile dysfunction (ED).
PubMed Central (PMC): A review article discusses the efficacy and safety of TADALISTA PROFESSIONAL in clinical populations, including men with ED and various comorbid conditions. The analysis of 11 double-blind, placebo-controlled trials with 2,102 men demonstrated significant improvements in erectile function with Tadalafil treatment.
For more personalized information or if you have specific questions about how Tadalista Professional might work for you, it's advisable to consult with a healthcare provider or a pharmacist. They can provide guidance tailored to your individual health needs and circumstances.
Add your comment